This bill matters because it directly addresses two major concerns for many Americans: the high cost of prescription drugs and medical device shortages. By making it easier for non-profit organizations to enter the market for manufacturing and distributing these products, the bill seeks to foster competition and provide alternatives to purely profit-driven entities.

If this bill becomes law, it could encourage new organizations to focus on public health needs, potentially leading to more innovation in affordable drugs and devices, especially in areas currently underserved. It could also strengthen the nation's ability to respond to public health emergencies by ensuring a more reliable supply of critical items for the Strategic National Stockpile. Without this legislation, non-profits might continue to face disincentives or legal ambiguity if they attempt to directly address these market failures through manufacturing and distribution.